Montair is recommended for the following conditions:
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Montelukast is a selective leukotriene receptor antagonist that blocks the CysLT1 receptor, responsible for mediating inflammation. Leukotrienes (LTC4, LTD4, LTE4)—produced from arachidonic acid by mast cells and eosinophils—play a key role in asthma and allergic rhinitis symptoms like airway swelling, smooth muscle contraction, and inflammation. By inhibiting these effects, Montelukast helps reduce the severity of symptoms associated with these respiratory conditions.
Adults and Adolescents (≥15 years):
Pediatric Dosage:
Can be given directly, or mixed with cold soft food or water.
Special Populations:
Common: Headache, nausea, vomiting, diarrhea, fever, GI discomfort, upper respiratory tract infection, skin rash.
Uncommon: Anxiety, dizziness, sleep disturbances, dry mouth, joint pain, mood changes, muscle aches.
Rare: Suicidal thoughts, memory issues, liver problems, hallucinations, angioedema, eosinophilic granulomatosis, tremors.
Montair has shown no significant interactions with commonly used asthma medications or agents like theophylline, prednisone, oral contraceptives, terfenadine, digoxin, and warfarin.
Montair can be co-administered safely with thyroid hormones, NSAIDs, sedatives, benzodiazepines, and decongestants.
However, Phenobarbital may reduce Montair’s plasma levels by about 40%. Clinical monitoring is advised when co-administered with enzyme inducers such as rifampin or phenobarbital.
Hypersensitivity to Montelukast or any of its components.
Pregnancy: Although animal studies show placental transfer, human data is lacking. Use only when necessary.
Breastfeeding: Caution is advised as Montelukast may be excreted in breast milk.